prostate cancer
Conditions
Interventions
Gold Standard:Pathological examination
Index test:PSMA/PET MRI
Sponsors
Beijing Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. prostate cancer diagnosed by histopathology; 2. prostate lesion within one lobe of prostate and visible on mp-MRI, with clinical stage of cT1-2bN0M0; 3. PSA<=15ng/mL; 4. life expectancy over 10 years; 5. Gleason score<=7; 6. with good endurance of mp-MRI and good compliance of follow up; 7. eligible for general anesthesia or epidural anesthesia; 8. with a signed inform consent and willing to take part in the follow-up program.
Exclusion criteria
Exclusion criteria: 1. local or distant metastasis detected by bone scan or other examination before operation; 2. a history of hormonal therapy within 12 months; 3. a history of transurethral resection of prostate within 6 months; 4. intolerable of transrectal ultrasonography due to a history of anus suggery; 5. intolerable of mp-MRI due to metal implant or other reason; 6. history of latex allergies; 7. with comorbidities of urethal stricture, bladder neck contracture, and urinary tract infection; 8. a historu of HIFU or other focal therapy on prostate cancer; 9. other conditions resulting in intolerance of focal therapy evaluated by a anesthetist; 10. severe kidney injury with a eGFR<35ml/min.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sensitivity;specifcity; | — |
Countries
China
Contacts
Public ContactLiu Ming
Beijing Hospital
Outcome results
None listed